2nd International Conference on Vaccine Research and Development (ICVRD-2024)
| When | Monday, April 22, 2024 - Wednesday, April 24, 2024 |
| Where | Munich Germany |
| Category | Vaccine |
| Organised by | Pangea Global Events |
| Share this page: |  |
 |
 |
 |
About the event
Our aim to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Vaccine Research and Development.
The Objective is to provide a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent solutions adopted in the fields of Vaccine Research and Development.
The topics covered in this event will include covid-19 Vaccine and Development, vaccine regulation & safety, new trends in vaccines development, Next generation vaccine technologies.
The conference will also feature keynote speakers from renowned universities as well as industry experts who will share their insights.
Our aim to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Vaccine Research and Development.
The Objective is to provide a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent solutions adopted in the fields of Vaccine Research and Development.
The topics covered in this event will include covid-19 Vaccine and Development, vaccine regulation & safety, new trends in vaccines development, Next generation vaccine technologies.
The conference will also feature keynote speakers from renowned universities as well as industry experts who will share their insights.
Plenary Speakers
| Barry T. Rouse | University of Tennessee USA |
| De-chu Christopher Tang | CEO of VaxDome Inc USA |
| Nagy Habib | Imperial College London United Kingdom |
| Graeme Ladds | CEO of PharSafer United Kingdom |
| Harry Kleanthous | SK Bioscience USA |
| Tomas Hanke | University of Oxford United Kingdom |
| Chil-Yong Kang | University of Western Ontario Canada |
| Trina Racine | Director of Vaccine Development Canada |
| Xiao-Qing Qiu | Sichuan University China |
| Petro Terblanche | CEO of Afrigen Biologics South Africa |
| Fatima Ferreira | University of Salzburg Austria |
| Alisher-Okhunov | Tashkent Medical Academy Uzbekistan |
Keynote Speakers
| Yongqun Oliver He | University of Michigan USA |
| Cody Wenthur | University of Wisconsin-Madison USA |
| Aykut Ozdarendeli | Erciyes University Turkey |
| Magdalena Tary-Lehmann | Cellular Technology Limited USA |
| Luca Roncati | University of Modena & Reggio Emilia Italy |
| Kalliopi Megari | Aristotle University of Thessaloniki Greece |
| Huang Wei Ling | Medical Acupuncture and Pain Management Clinic Brazil |
| Mostafa Abbas Shalaby | Cairo University Egypt |
| Márcia CA Fantini | University of Sao Paulo Brazil |
| Rami Hani Al-Rifai | United Arab Emirates University United Arab Emirates |
| Solomon I. Ubani | Metropolitan University United Kingdom |
| Paulo Ricardo Martins-Filho | Federal University of Sergipe Brazil |
| Anjula Gurtoo | Indian Institute of Science India |
Invited Speakers
| Greg A. Kirchenbaum | Cellular Technology Limited USA |
| Juliana Melgaço | Immune Technology Laboratory Brazil |
| Daniel A.M. Villela | Columbia University Brazil |
| Joaquín Álvarez Norambuena | University of Minnesota USA |
| Muluken Basa | Trinity College Dublin Ireland |
| Lorna Galleguillos | Clinica Alemana Santiago < br/> Chile |
| Daniela Alejandra Loaiza Martinez | Indoamerica University Ecuador |
| Neveen Gerges Zaki | Ministry of Health and Population Egypt |
| Desmond MaadaKangbai | Njala University Sierra Leone |
| Rachna Chaturvedi | Amity University India |
Scientific Sessions
- Covid-19 Vaccine Research and Development
- Cancer, Malaria and TB Vaccines
- Vaccine Regulation, Safety and Efficacy
- Vaccines against Neurological Infections
- Veterinary Vaccinology
- Nano Vaccine Technology
- Next Generation Vaccines Delivery Technologies
- HIV/AIDS Vaccines
- Vaccine Storage and Handlings
- Vaccines for Vector-Borne Diseases
- Vaccines for Pregnant Women and Neonates
- Hepatitis Vaccines and Liver Diseases
- Animal and Plant Derived Vaccines
- Infectious &Non-infectious diseases
- New Trends in Vaccines Development
- Vaccines Misperception and Side Effects
- Live-Attenuates Vaccines
- Analytical Method Life Cycle, Analytical QbD and Vaccines release testing
- Immunology of Infectious Diseases
- Influenza Vaccines
- Conjugate Vaccine
- Emerging & Re-Emerging Diseases
- Bioprocessing & Manufacturing of vaccines
- Vaccine Adjuvants
- Antimicrobials/Antibiotics/Antibacterial
- Geriatric Immunization
- Immuno-Pathology
- Vaccines for Respiratory Diseases
- Ebola Vaccine
- Mucosal Vaccines